🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to evaluate the efficacy, safety, and tolerab...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-07-21
Trial ID
NCT04732117
Treatments Being Tested
This was a randomized, double-blind, parallel, multicenter, multinational s...
Status
Completed
Location
AES - DRS - Medical Center Synexus Sofia EOOD
Start Date
2022-03-16
Trial ID
NCT05338086
Treatments Being Tested
The purpose of the study is to assess the bioavailability (the extent to wh...
Status
Completed
Location
Multiple Locations
Start Date
2014-03
Trial ID
NCT02079545
This study aims to evaluate the efficacy, safety and tolerability, pharmaco...
Status
Terminated
Location
Thrive Health - Beverly Hills
Start Date
2024-03-27
Trial ID
NCT06307613
Treatments Being Tested
This study is part of the ADAPT Forward platform study (NCT07294170). ADAPT...
Status
Recruiting
Location
Visionary Investigators Network
Start Date
2026-07-10
Trial ID
NCT07673627
Treatments Being Tested
The study will compare the safety of ophthalmic bevacizumab in vials versus...
Status
Active Not Recruiting
Location
Clinical Site
Start Date
2021-11-15
Trial ID
NCT05112861
Treatments Being Tested
The purpose of this study is to characterize the pharmacokinetic (PK) profi...
Status
Completed
Location
Research Site
Start Date
2012-06
Trial ID
NCT01610310
The purpose of this study is to demonstrate similar efficacy and safety bet...
Status
Completed
Location
Teva Site 103
Start Date
2021-03-22
Trial ID
NCT04729621
The main purpose of this study is to look at the amount of the study drug, ...
Status
Completed
Location
LabCorp CRU, Inc.
Start Date
2021-06-02
Trial ID
NCT04840901
Treatments Being Tested
The objective of this study is to evaluate the bioavailability of risankizu...
Status
Completed
Location
Acpru /Id# 210844
Start Date
2019-04-02
Trial ID
NCT05283681
Treatments Being Tested